e-learning
resources
Berlin 2001
Sunday 23.09.2001
Inflammation, infection and exercise capacity in cystic fibrosis patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytokine production in whole blood and disease severity in cystic fibrosis
S. Schmitt-Grohe, C. Naujoks, R. Schubert, J. Bargon, T. O. Wagner, S. Zielen (Bonn, Frankfurt, Germany)
Source:
Annual Congress 2001 - Inflammation, infection and exercise capacity in cystic fibrosis patients
Session:
Inflammation, infection and exercise capacity in cystic fibrosis patients
Session type:
Thematic Poster Session
Number:
853
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Schmitt-Grohe, C. Naujoks, R. Schubert, J. Bargon, T. O. Wagner, S. Zielen (Bonn, Frankfurt, Germany). Cytokine production in whole blood and disease severity in cystic fibrosis. Eur Respir J 2001; 16: Suppl. 31, 853
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005
Aspergillus
-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity
Source: ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017
Year: 2018
Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis
Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017
Year: 2018
Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Arginase in patients with cystic fibrosis airway disease
Source: Annual Congress 2004 - Cystic fibrosis in the 21
st
century: cutting edge investigations, taxing problems
Year: 2004
Increased CCL18 production in interstitial lung diseases is associated with fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
Circulating inflammatory cytokines in adult cystic fibrosis patients
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Decreased expression of HLA-DQ and -DR on blood monocytes, sputum macrophages and monocyte-derived macrophages in patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
The RANKL-OPG balance in pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Role of interleukin-10 in idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 23: 179-180
Year: 2004
Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept